Jim and Geri Taylor

Geri Taylor has an MPH from Columbia University with a concentration in biostatistics and an RN degree. During her forty-five year career, she was a successful health care executive in New York City, serving in senior executive positions at Beth Abraham Hospital and the Jewish Guild for the Blind. Ms. Taylor’s legacy includes developing a Medicare/Medicaid program to provide medical services to nursing home eligible seniors, enabling them to remain at home. This program is now serving approximately eighty thousand people in New York City. Jim Taylor has a math degree from DePauw University and an MBA from the University of Chicago. Mr. Taylor’s military service in the US Army included tours in Washington and Europe. During his 30 years in IBM finance, Mr. Taylor served four years as President of the Board of Education in White Plains, NY. Ms. Taylor was diagnosed with Alzheimer’s disease in 2012, and since that time the couple have spoken to over ten thousand people around the US and Europe in order to educate others about the disease, reduce stigma, and encourage participation in clinical trials. On May 1, 2016 the New York Times published an acclaimed twelve-page article entitled, Fraying at the Edges,(https://www.nytimes.com/interactive/2016/05/01/nyregion/living-wit-alzheimers.html) as a special section of the paper about Geri Taylor’s journey with Alzheimer’s. In July 2017, Ms. Taylor spoke to the Board of Directors of the Alzheimer’s Association at the Alzheimer’s Association International Conference (AAIC) in London. In December, 2017, the couple spoke at the OECD International Alzheimer’s Conference in Switzerland. In addition to their speaking engagements, Geri and Jim Taylor are actively engaged in several national Alzheimer’s projects, serving on executive steering committees. Mr. Taylor serves as an FDA appointed Alzheimer’s Patient Advocate, attending FDA meetings to review new drugs and devices. In March, 2020, the couple spoke to 900 US Biogen employees in Orlando and was subsequently invited to speak to the Biogen Board of Directors in Boston. Ms. Taylor has been in Biogen’s phase 1B drug trial for aducanumab since 2014, and the couple was invited to speak at the FDA’s ADCOM meeting on aducanumab in November, 2020. On September 15, 2020, Geri and Jim Taylor were awarded the Perennial Hero Award by Alliance for Aging Research for their Alzheimer’s advocacy. Due to COVID – 19, Ms. Taylor was unable to meet her fellow recipient, Dr Anthony Fauci, who received the Hero of Science Award.